Company news
ValiRx PLC news in 2019
ValiRx PLC's news releases, calls and decks from 2019, newest first.
VAL201 Update
December 16, 2019
US Patent Grant re VAL201 & Metastatic Cancer
November 28, 2019
Appointment of Joint Broker
November 13, 2019
Passing of Non-Executive Chairman
October 21, 2019
Placing & Issue of Equity
October 14, 2019
Company Update
September 24, 2019
Company Update & Change of Adviser
August 6, 2019
New European patent allowance for VAL301
August 1, 2019
Marketing and Communications Update
July 10, 2019
Change of Registered Address
July 9, 2019
Update re VAL301
July 4, 2019
US Notice of Allowance-VAL201 & Metastatic Cancer
June 26, 2019
Further re: Termination of Subscription Agreement
June 25, 2019
Update on VAL201 Clinical Trial
June 20, 2019
Placing, Subscription Agreement & Issue of Warrant
June 13, 2019
Subscription Agreement Update
June 10, 2019
Notice of AGM & Update of Subscription Agreement
June 5, 2019
Acquisition of Intellectual Property& JV Agreement
May 2, 2019
Subscription, Convertible Funds and Warrant Issue
April 26, 2019
Valirx (VAL): VAL401 is going forward
April 15, 2019
ValiSeek Update
March 26, 2019
Update on VAL201 & VAL301 Development Progress
March 21, 2019
Placing, Issue of Equity and Warrant
February 21, 2019
New patent grant allowances for VAL301
January 31, 2019
Publication of VAL401 peer-reviewed article
January 11, 2019
ValiRx endorses the Government's new NHS strategy
January 9, 2019